Enliven Therapeutics Inc
ELVN18.750USD
+0.020+0.11%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
919.48MMarket Cap
LossP/E TTM
Enliven Therapeutics Inc
18.750
+0.020+0.11%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q2
FY2019Q1
Operating expenses
21.96%31.69M
18.33%26.90M
11.63%27.07M
22.20%24.60M
58.28%25.99M
597.85%22.73M
401.93%24.25M
74.76%20.13M
11.98%16.42M
-77.28%3.26M
-64.63%4.83M
-12.51%11.52M
42.62%14.66M
24.10%14.33M
9.32%13.66M
27.83%13.17M
39.83%10.28M
--11.55M
--12.49M
85.39%10.30M
75.30%7.35M
--5.56M
--4.19M
R&D expenses
24.66%24.89M
15.74%20.72M
8.43%21.26M
23.99%18.83M
68.10%19.97M
9847.22%17.91M
10672.53%19.61M
104.93%15.18M
6.37%11.88M
-98.34%180.00K
-98.25%182.00K
-26.45%7.41M
56.98%11.17M
21.17%10.86M
9.06%10.40M
28.02%10.07M
22.82%7.12M
--8.96M
--9.53M
80.23%7.87M
62.72%5.79M
--4.37M
--3.56M
Depreciation, depletion, and amortization
-6.33%74.00K
0.00%80.00K
1.27%80.00K
6.76%79.00K
17.91%79.00K
--80.00K
-24.04%79.00K
-84.68%74.00K
168.00%67.00K
----
333.33%104.00K
1832.00%483.00K
0.00%25.00K
8.70%25.00K
-4.00%24.00K
0.00%25.00K
4.17%25.00K
--23.00K
--25.00K
--25.00K
--24.00K
----
--0.00
Operating profit
-21.96%-31.69M
-18.33%-26.90M
-11.63%-27.07M
-22.20%-24.60M
-58.28%-25.99M
-597.85%-22.73M
-401.93%-24.25M
-74.76%-20.13M
-11.98%-16.42M
77.28%-3.26M
64.63%-4.83M
12.51%-11.52M
-42.62%-14.66M
-24.10%-14.33M
-9.32%-13.66M
-27.83%-13.17M
-39.83%-10.28M
---11.55M
---12.49M
-85.39%-10.30M
-75.30%-7.35M
---5.56M
---4.19M
Net non-operating interest income (expenses)
Non-operating interest income
-1.66%3.20M
10.33%3.72M
9.94%3.84M
19.72%4.09M
91.85%3.25M
556.53%3.37M
1342.98%3.49M
3002.73%3.41M
2071.79%1.69M
612.50%513.00K
706.67%242.00K
129.17%110.00K
-6.02%78.00K
-37.39%72.00K
-76.19%30.00K
-56.36%48.00K
-37.12%83.00K
--115.00K
--126.00K
-31.25%110.00K
--132.00K
--160.00K
--0.00
Special income (expenses)
----
--0.00
--73.00K
--800.00K
----
----
----
----
----
--0.00
---200.00K
----
----
----
----
----
----
----
----
----
----
----
----
- Gains from disposal of fixed assets
----
----
----
----
----
----
----
----
----
--35.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
-4600.00%-47.00K
100.00%0.00
100.00%0.00
---1.00K
---1.00K
-152.94%-9.00K
-107.22%-13.00K
----
----
129.82%17.00K
1100.00%180.00K
5.00%-38.00K
6.67%-56.00K
31.33%-57.00K
67.27%-18.00K
-233.33%-40.00K
-1300.00%-60.00K
---83.00K
---55.00K
---12.00K
--5.00K
--0.00
--0.00
Income before tax
-25.53%-28.54M
-19.67%-23.18M
-11.49%-23.16M
-17.92%-19.72M
-54.43%-22.74M
-160.02%-19.37M
-350.62%-20.77M
-46.05%-16.72M
-0.58%-14.72M
325.39%32.27M
66.23%-4.61M
13.01%-11.45M
-42.72%-14.64M
-24.32%-14.32M
-9.85%-13.65M
-28.98%-13.16M
-42.16%-10.26M
---11.52M
---12.42M
-89.07%-10.20M
-72.03%-7.21M
---5.40M
---4.19M
Income tax
----
--0.00
--0.00
--232.00K
----
----
----
----
----
--88.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
-25.53%-28.54M
-19.67%-23.18M
-11.49%-23.16M
-19.31%-19.95M
-54.43%-22.74M
-160.18%-19.37M
-350.62%-20.77M
-46.05%-16.72M
-0.58%-14.72M
324.77%32.19M
66.23%-4.61M
13.01%-11.45M
-42.72%-14.64M
-24.32%-14.32M
-9.85%-13.65M
-28.98%-13.16M
-42.16%-10.26M
---11.52M
---12.42M
-89.07%-10.20M
-72.03%-7.21M
---5.40M
---4.19M
Net income from continuous operations
-25.53%-28.54M
-19.67%-23.18M
-11.49%-23.16M
-19.31%-19.95M
-54.43%-22.74M
-160.18%-19.37M
-350.62%-20.77M
-46.05%-16.72M
-0.58%-14.72M
324.77%32.19M
66.23%-4.61M
13.01%-11.45M
-42.72%-14.64M
-24.32%-14.32M
-9.85%-13.65M
-28.98%-13.16M
-42.16%-10.26M
---11.52M
---12.42M
-89.07%-10.20M
-72.03%-7.21M
---5.40M
---4.19M
Net income attributable to controlling interests
-25.53%-28.54M
-19.67%-23.18M
-11.49%-23.16M
-19.31%-19.95M
-54.43%-22.74M
-160.18%-19.37M
-350.62%-20.77M
-46.05%-16.72M
-0.58%-14.72M
324.77%32.19M
66.23%-4.61M
13.01%-11.45M
-42.72%-14.64M
-24.32%-14.32M
-9.85%-13.65M
-28.98%-13.16M
31.95%-10.26M
---11.52M
---12.42M
-89.07%-10.20M
-259.39%-15.07M
---5.40M
---4.19M
Preferred share dividend
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
----
----
--0.00
--7.86M
----
--0.00
Net income attributable to common shareholders
-25.53%-28.54M
-19.67%-23.18M
-11.49%-23.16M
-19.31%-19.95M
-54.43%-22.74M
-160.18%-19.37M
-350.62%-20.77M
-46.05%-16.72M
-0.58%-14.72M
324.77%32.19M
66.23%-4.61M
13.01%-11.45M
-42.72%-14.64M
-24.32%-14.32M
-9.85%-13.65M
-28.98%-13.16M
31.95%-10.26M
---11.52M
---12.42M
-89.07%-10.20M
-259.39%-15.07M
---5.40M
---4.19M
Basic earnings per share
-5.46%-0.57
1.18%-0.46
5.22%-0.48
-1.66%-0.41
32.00%-0.54
-109.60%-0.47
27.82%-0.51
76.57%-0.41
64.30%-0.80
325.27%4.90
68.01%-0.70
41.38%-1.74
4.57%-2.23
16.90%-2.17
23.45%-2.19
-25.19%-2.97
86.48%-2.33
---2.62
---2.86
-82.26%-2.37
-1605.30%-17.26
---1.30
---1.01
Diluted earnings per share
-5.46%-0.57
1.18%-0.46
5.22%-0.48
-1.66%-0.41
32.00%-0.54
-109.75%-0.47
27.82%-0.51
76.57%-0.41
64.30%-0.80
321.95%4.83
68.01%-0.70
41.38%-1.74
4.57%-2.23
16.90%-2.17
23.45%-2.19
-25.19%-2.97
86.48%-2.33
---2.62
---2.86
-82.26%-2.37
-1605.30%-17.26
---1.30
---1.01
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
